|
| Trifluoperazine |
|
Neisseria |
Type IV pili |
Preclinical (in vivo) |
Denis K, et al. 2019. Nat Microbiol |
|
| Punicalagin |
|
Staphylococcus |
Others; Adherence; Biofilm |
Preclinical (in vivo) |
Song W, et al. 2022. Antimicrob Agents Chemother |
|
| Taxifolin |
|
Staphylococcus |
Others; Adherence; Biofilm |
Preclinical (in vivo) |
Wang L, et al. 2021. Front Microbiol |
|
| Hibifolin |
|
Staphylococcus |
Others; Adherence; Biofilm |
Preclinical (in vivo) |
Song W, et al. 2022. Microbiol Spectr |
|
| Fusidic acid |
|
Staphylococcus |
α-hemolysin |
Preclinical (in vivo) |
Liu L, et al. 2020. Front Microbiol |
|
| Solonamide B |
|
Staphylococcus |
δ-hemolysin |
Preclinical (in vivo) |
Baldry M, et al. 2018. J Infect Dis |
|
| Orientin |
|
Staphylococcus |
Others |
Preclinical (in vivo) |
Wang L, et al. 2021. Virulence |
|
| Cyanidin chloride |
|
Staphylococcus |
Others; Adherence; Biofilm |
Preclinical (in vivo) |
Su X, et al. 2022. Virulence |
|
| Erianin |
|
Staphylococcus |
FnBPs (Fibronectin binding proteins) |
Preclinical (in vivo) |
Ouyang P, et al. 2018. Toxins (Basel) |
|
| 2-(5-(4-(Benzyloxy)benzylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid |
|
Staphylococcus |
α-hemolysin |
Preclinical (in vivo) |
Gao P, et al. 2018. Proc Natl Acad Sci U S A |
|
| | | |
